West Pharmaceutical
714 hedge funds and large institutions have $28.2B invested in West Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 74 funds opening new positions, 245 increasing their positions, 277 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
12% less repeat investments, than reductions
Existing positions increased: 245 | Existing positions reduced: 277
12% less capital invested
Capital invested by funds: $32B → $28.2B (-$3.79B)
Holders
714
Holding in Top 10
10
Calls
$79.6M
Puts
$84.4M
Top Buyers
| 1 | +$300M | |
| 2 | +$219M | |
| 3 | +$162M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$70.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$57.2M |
Top Sellers
| 1 | -$103M | |
| 2 | -$89.7M | |
| 3 | -$78.2M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$62M |
| 5 |
Morgan Stanley
New York
|
-$61.1M |